-+ 0.00%
-+ 0.00%
-+ 0.00%

Tvardi Therapeutics Q4 EPS $(0.78) Misses $(0.68) Estimate

Benzinga·03/31/2026 21:14:28
Listen to the news
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.68) by 15.38 percent. This is a 84.21 percent increase over losses of $(4.94) per share from the same period last year.